Signia Therapeutics, Cynbiose and the VirPath academic laboratory are partnering on an ambitious collaborative R&D project to advance the development of innovative therapeutic treatments in the field of respiratory infections. The METABIOSE project is winner of he 2019 R&D Booster award, supported by the Regional Innovation Fund of the Auvergne Rhône Alpes region. Read more
